Optimizing the management of patients with spinal myeloma disease
Sean Molloy(Royal National Orthopaedic Hospital), Isobel Chalmers(Ipswich Hospital), Jeremy Reynolds(Oxford University Hospitals NHS Trust), Gordon Cook(University of Leeds), Alastair Hamilton(Musgrove Park Hospital), Bronek M. Boszczyk(Queen's Medical Centre), Sam H. Ahmedzai(University of Sheffield), Guy Pratt(University Hospitals Birmingham NHS Foundation Trust), Susanne Selvadurai(Royal National Orthopaedic Hospital), Martin J. Auger(Norfolk and Norwich University Hospital), Maqsood Punekar(Lancashire Teaching Hospitals NHS Foundation Trust), Karthik Ramasamy(Oxford University Hospitals NHS Trust), Maggie Lai(Myeloma UK), Eric Low(Myeloma UK), Charalampia Kyriakou(The Royal Free Hospital), Nasir A. Quraishi(Queen's Medical Centre), Cathy Williams(The University of Texas System), D. Timothy Bishop(University of Leeds), Jane Tighe, David C. Cumming(University of Alberta), David Wilson(Brooke Army Medical Center), Michael Quinn(University of Ulster), Alistair J. Stirling(Royal Orthopaedic Hospital), Niall Craig(Woodend Hospital), Mel Grainger(Royal Orthopaedic Hospital), Debo Ademonkun(Ipswich Hospital), Fenella Willis(St George's Hospital)
Cited by 32
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
|European Journal of Cancer|1994|878
Gene for von Recklinghausen Neurofibromatosis Is in the Pericentromeric Region of Chromosome 17
|Science|1987|698
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
|Nature Communications|2020|694